newsfilter
← Latest News
GlobeNewswire·

Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress

HOUSTON, May 24, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of